Immunomodulators

Rossen Donev received his PhD degree in 1999 from the Institute of Molecular Biology, Bulgarian Academy of Sciences. He did postdoctoral training at Imperial Cancer Research Fund and Cardiff University. In 2007 he was awarded a New Investigator Grant Award from the Medical Research Council (UK) to establish himself as an independent Principal Investigator. In 2010 Dr. Donev was appointed Senior Lecturer at Swansea University. In 2016 Dr. Donev joined MicroPharm Ltd (UK) where currently he is Head of Research. He has published more than 60 research papers, chaired scientific meetings, and given invited plenary talks. Rossen Donev has consulted on projects related to the development of treatments for neurodevelopmental disorders and cancer therapies. He serves as Editor-in-Chief of Advances in Protein Chemistry and Structural Biology and sits on the editorial board of several other journals. His research interests include signaling pathways involved in neuropsychiatric disorders and tumor escape from the immune system, and the development of therapeutic strategies for their treatment. More recently, he has focused on the development of immunotherapeutics for non-systemic applications.